UNTHSC Logo
Catalog 2014 - 2015

SCP Course Descriptions

PHAR 7110. IPPE 1

2 SCH. Students are trained in Basic Life Support (BLS), participate in health fairs coordinated &/or sponsored by UNTHSC and are oriented and begin the Seniors Assisting in Geriatric Education (SAGE) program (see description below). At health fairs, students may screen patients for one or more of the following: hypertension, diabetes, high cholesterol, obesity, and osteoporosis.

PHAR 7116. Clinical Case Discussions 1

1 SCH. A series of courses designed to develop, foster and improve problem-solving, team building, critical thinking, self-directed learning and interpersonal skills centered on introductory concepts in patient care. Included is a strong emphasis on professional values and behaviors, attitudes, interprofessional experiences, and cultural competence. Team-based learning formats are utilized.

PHAR 7120. IPPE 2

1 SCH. Is a continuation of 7110. Students receive immunization certification training and complete simulations in this course.

PHAR 7126. Clinical Case Discussions 2

1 SCH. A series of courses designed to develop, foster and improve problem-solving, team building, critical thinking, self-directed learning and interpersonal skills centered on introductory concepts in patient care. Included is a strong emphasis on professional values and behaviors, attitudes, interprofessional experiences, and cultural competence. Team-based learning formats are utilized.

PHAR 7130. IPPE 4

2 SCH. Students continue participation in the SAGE program and health fairs that may include students providing immunizations to participants under supervision of a preceptor.

PHAR 7136. Integrated Pharmacy Recitation 1

1 SCH. A series of courses designed to develop, foster and improve problem solving, team building, critical thinking, self-directed learning and interpersonal skills. Clinical patient cases are used to integrate the relevant pathophysiology, medicinal chemistry, pharmacology and pharmacotherapy with social/behavioral pharmacy principles involved in the treatment of a variety of diseases in a variety of patients. Case discussions involve material being presented in the Integrated Pharmacotherapy sequence and include a strong emphasis on professional values and behaviors, attitudes, interprofessional experiences, and cultural competence. Team-based learning formats are utilized.

PHAR 7137. Pharmacy Practice Skills Laboratory 3

1 SCH. A continuation of the Skills Lab sequence concentrating on pharmacy calculations and sterile compounding.

PHAR 7140. IPPE 5

2 SCH. is a continuation of 7130. Students receive training and simulations in Medication Therapy Management (MTM) and medication reconciliation or transition of care.

PHAR 7146. Integrated Pharmacy Recitation 2

1 SCH. A series of courses designed to develop, foster and improve problem solving, team building, critical thinking, self-directed learning and interpersonal skills. Clinical patient cases are used to integrate the relevant pathophysiology, medicinal chemistry, pharmacology and pharmacotherapy with social/behavioral pharmacy principles involved in the treatment of a variety of diseases in a variety of patients. Case discussions involve material being presented in the Integrated Pharmacotherapy sequence and include a strong emphasis on professional values and behaviors, attitudes, interprofessional experiences, and cultural competence. Team-based learning formats are utilized.

PHAR 7147. Pharmacy Practice Skills Laboratory 4

1 SCH. A continuation of the Skills Lab sequence concentrating on drug literature evaluation and the incorporation of evidenced based guidelines into practice.

PHAR 7150. IPPE 7

SCH. Students participate in MTM in the community setting and medication reconciliation in the institutional setting. Students complete a medication literacy project that is presented to a targeted audience.

PHAR 7156. Integrated Pharmacy Recitation 3

1 SCH. A series of courses designed to develop, foster and improve problem solving, team building, critical thinking, self-directed learning and interpersonal skills. Clinical patient cases are used to integrate the relevant pathophysiology, medicinal chemistry, pharmacology and pharmacotherapy with social/behavioral pharmacy principles involved in the treatment of a variety of diseases in a variety of patients. Case discussions involve material being presented in the Integrated Pharmacotherapy sequence and include a strong emphasis on professional values and behaviors, attitudes, interprofessional experiences, and cultural competence. Team-based learning formats are utilized.

PHAR 7160. IPPE 8

1 SCH. is a continuation of 7150. In addition, students are trained in Advanced Cardiovascular Life Support (ACLS) with the use of high-fidelity manikin simulation of a code, i.e., treatment of a hospitalized patient with a myocardial infarction. This exercise will also include physician assistant and medical students.

PHAR 7166. Integrated Pharmacy Recitation 4

1 SCH. A series of courses designed to develop, foster and improve problem solving, team building, critical thinking, self-directed learning and interpersonal skills. Clinical patient cases are used to integrate the relevant pathophysiology, medicinal chemistry, pharmacology and pharmacotherapy with social/behavioral pharmacy principles involved in the treatment of a variety of diseases in a variety of patients. Case discussions involve material being presented in the Integrated Pharmacotherapy sequence and include a strong emphasis on professional values and behaviors, attitudes, interprofessional experiences, and cultural competence. Team-based learning formats are utilized.

PHAR 7214. Pharmacotherapy of Self-Care 1

2 SCH. The pharmacists role in facilitating patient self-care through the treatment of minor ailments, non-prescription pharmaceutical pharmaceuticals and supplies commonly found in ambulatory pharmacy practice sites, use of complementary and alternative products and their limitations, decision making skills for ambulatory patient triage, and home diagnostic products. Conditions covered include headache, fever, musculoskeletal injuries, cough and cold, allergies, asthma, menstrual disorders, and various dermatologic disorders.

PHAR 7217. Pharmacy Practice Skills Laboratory 1

2 SCH. The first in a series of laboratories designed to teach and reinforce various skills, attitudes, behaviors and values needed for pharmacy practice. Included are principles of patient assessment, pharmacy calculations and the Top 200 Drugs. Includes some interprofessional experiences.

PHAR 7224. Pharmacotherapy of Self-Care 2

2 SCH. A continuation of 7214 concentrating on insomnia and fatigue, smoking cessation, nutrition, nutraceuticals, obesity, gastro-intestinal disorders, urinary incontinence, hemorrhoids and occult blood, and parasitic infections.

PHAR 7227. Pharmacy Practice Skills Laboratory 2

2 SCH. A continuation of the Skills Lab sequence concentrating on pharmacy calculations, extemporaneous compounding and patient education.

PHAR 7229. IPPE 3

2 SCH. Students are introduced to community pharmacy practice during this rotation. Objectives are listed in Table 14-2. Some of these are described in the APhA Community Preceptor Education Program publication.

PHAR 7232. Principles of Medicinal Chemistry and Pharmacology

2 SCH. The pre-requisite principles needed for the integrated pharmacotherapy sequence including terminology, chemical properties influencing ADME, pharmacophores, SAR, receptor theory, drug receptor and transporter interactions, mechanisms of action, dose-response and time-response relationships, and drug discovery and development.

PHAR 7249. IPPE 6

2 SCH. Students are introduced to institutional pharmacy practice during this rotation. Objectives are listed in Table 14-3. Some of these are described in the 2010 ASHP-ACPE Joint Task Force Report on Entry-level Competencies.

PHAR 7262. Integrated Pharmacotherapy 8: MS Connective Tissue Dx

2 SCH. A continuation of 7534 concentrating on diseases affecting the musculo-skeletal system and connective tissues.

PHAR 7263. Integrated Pharmacotherapy 9 : Special Populations

2 SCH. A continuation of 7534 concentrating on pharmacotherapy issues in special populations i.e. pediatric, geriatric, obese etc. patients.

PHAR 7264. Integrated Pharmacotherapy 10: Critical Care

2 SCH. A continuation of 7534 concentrating on the pharmacotherapy of critically ill patients.

PHAR 7313. Pharmaceutics 1

3 SCH. An introduction to dosage forms and their physiochemical properties to optimize stability, absorption and distribution to target tissues. Includes solubility, crystalline and amorphous solids, oral drug delivery systems, dissolution versus disintegration, drug solutions and drug solids, polymers and macromolecules, emulsions and suspensions, micelles, colloids, and excipients.

PHAR 7315. Introduction to Pharmacy Practice 1: The Profession

3 SCH. An introduction to pharmacy practice including prescription components and who can prescribe, evolution of practice, history, career pathways, basic ethics and professionalism, education, basic legal issues and responsibilities for interns, health care delivery systems, medication safety, basic drug information, and advocacy/leadership.

PHAR 7321. Pharmacotherapy of Infectious Disease

3 SCH. The fundamental concepts regarding microbiological agents known to cause disease in humans, infectious conditions and their prevention and management, and the principles of anti-infective agent use and their implementation in patients and health systems.

PHAR 7322. Pharmacogenetics, Pharmacogenomics, and Personalized Medicine

3 SCH. The principles of pharmacogenetics and genomics and how they relate to personalized medicine including nomenclature; the genetic basis of diseases, drug response and metabolism; biomarkers for adverse drug reactions; toxicogenetics; legal/ethical and economic issues; and implications for managing drug therapy.

PHAR 7323. Pharmaceutics 2

3 SCH. The factors influencing absorption, distribution, metabolism and excretion of drugs in contemporary and investigational dosage forms. Includes modified release oral and parenteral, topical, nasal, buccal, rectal, vaginal, ophthalmic and pulmonary delivery systems; prodrugs; bioequivalence determinations and ratings; and official compendia.

PHAR 7325. Introduction to Pharmacy Practice 2: Communications

3 SCH. An introduction to factors and methods involved in interpersonal communication. Exposure to verbal, written and electronic communication with patients and between health care providers; verbal cues; strategies to facilitate communication with difficulty patients and sensitive health situations are included.

PHAR 7331. Immune Based Diseases and Immunotherapy

3 SCH. A study of the immune system, immunopathologies, select autoimmune disease and their treatment. Includes a discussion of the basis for immunizations, the immunology of cancer, biotechnology and its application to the production and use of pharmaceuticals, diagnostic agents and advanced therapies.

PHAR 7335. Introduction to Pharmacy Practice 3: Pharmaceutical Policy, Public Health and Pharmacoeconomics

3 SCH. An introduction to pharmaceutical policy, public health and pharmaco-economics with international comparisons. Includes issues of access to and disparities in healthcare, epidemiology, cost-benefit analysis, emergency preparedness, and policy assessment tools.

PHAR 7341. Integrated Pharmacotherapy 2: Endocrine/Men & Women's Health

3 SCH. A continuation of 7534 concentrating on diseases and treatments involving the endocrine system and male/female health.

PHAR 7343. Pharmacokinetics

3 SCH. The mathematical models and the theoretical/practical considerations of drug absorption, distribution and excretion including the models that describe those events in the calculation of dosage regimens for patients with problems ranging from simple to complex and concentrating on dosage calculations for drugs with narrow therapeutic indices.

PHAR 7345. Introduction to Pharmacy Practice 4: Evidence Based Practice and Literature Evaluation

3 SCH. Sources of drug information, drug study design and evaluation, and applied data analysis and biostatistics in the interpretation and critical analysis of biomedical literature needed to develop and utilize evidence-based recommendations for patients and health care practitioners.

PHAR 7352. Integrated Pharmacotherapy 5: Respiratory & GI

3 SCH. A continuation of 7534 concentrating on diseases and treatments involving the respiratory and gastro-intestinal systems.

PHAR 7353. Integrated Pharmacotherapy 6: Neuro & Psych & Pain

3 SCH. A continuation of 7534 concentrating on treatment of neurologic and psychiatric disorders and acute/chronic pain.

PHAR 7354. Optimizing Wellness

3 SCH. The approaches, strategies, and skills needed by pharmacists to optimize wellness in their patients; improve and document changes in outcomes as a direct result of pharmacist interventions; and skills needed to modify behaviors in patients.

PHAR 7355. Intro to Pharm Prac 5: Management & Safety

3 SCH. Pharmacy practice management in both community and health system practice settings including general business, human, financial and operations management; marketing clinical services; persuasion and organization transformation; national patient safety goals related to medication; and quality assurance/risk reduction.

PHAR 7361. Integrated Pharmacotherapy 7: Hem/Onc/Transplant

3 SCH. A continuation of 7534 concentrating on diseases affecting the blood, cancer and pharmacotherapy in organ transplants.

PHAR 7365. Introduction to Pharmacy Practice 6: Law and Ethics

4 SCH. The legal, ethical and access issues affecting the practice of pharmacy and regulating pharmacy practitioners. Included are discussions of ethical dilemmas, issues involving team based health care, health insurance and mandates, pharmacy benefit and management programs, and health maintenance organizations.

PHAR 7411. Physiologic Basis for Pharmacotherapy

4 SCH. The fundamental aspects of the physiologic basis for pharmacotherapy covering the physiology of the major organ systems of the body including both molecular and organismic function and interrelationships. Physiologic processes that underlie disease process and/or targets of drug therapy are emphasized.

PHAR 7412. Metabolic Basis for Pharmacotherapy

4 SCH. The fundamental aspects of the metabolic basis for pharmacotherapy covering the molecular basis of cellular function and control mechanisms, key structural and functional relationships of biomolecules, energy metabolism, and inter-organ relationships in living systems with an emphasis on processes that underlie disease and/or are targets of drug therapy.

PHAR 7442. Integrated Pharmacotherapy 3: Cardiovascular

4 SCH. A continuation of 7534 concentrating on diseases and treatments involving the cardiovascular system.

PHAR 7451. Integrated Pharmacotherapy 4: Infectious Disease

4 SCH. A continuation of 7534 concentrating on the treatment of infectious diseases.

PHAR 7534. Integrated Pharmacotherapy 1: Renal, Eye, Ear, Nose, Throat, and Skin

5 SCH. An integration of the relevant pathophysiology, medicinal chemistry, pharmacology and pharmacotherapy involved in the treatment of a variety of diseases. Included are comparisons to complimentary and alternative treatments, evidenced based guidelines and the pharmacokinetic calculations involved in dosing in various populations. This course concentrates on diseases and treatments involving the kidney, eye, ear, nose, throat and skin.

PHAR 7680. APPE: Elective

6 SCH. Students may choose elective rotations from the specialized patient care areas such as infectious diseases, psychiatry, oncology, neurology, geriatrics, palliative care, pediatrics, rural pharmacy, or critical care or from the non-direct patient care areas such as state or federal regulatory agencies, state or national organizations, research, managed care, nuclear pharmacy, academia, poison center or drug information. Each student will complete two APPE elective courses.

PHAR 7681. APPE: Required Rotation: Inpatient/Acute General Care Medicine

6 SCH. Students are involved in direct care of hospitalized patients in concert with other healthcare providers. This is a required course.

PHAR 7682. APPE: Required Rotation: Community Pharmacy

6 SCH. Students participate in all operations of a community pharmacy. Students provide pharmaceutical care to community pharmacy patients under the supervision of a pharmacist preceptor. This is a required course.

PHAR 7683. APPE: Required Rotation: Selective of Community or Hospital/Health System Pharmacy

6 SCH. Students may choose from a community pharmacy management, hospital pharmacy management, ambulatory care management or specialty disease state or population rotation to satisfy the APPE Selective Required rotation. Within the management rotations, the student's training is focused on understanding the budgetary, formulary and operational policies and procedures of the practice setting. The students will complete a management project or proposal during this rotation. For a listing of specialty disease states or populations, please see PHAR 7680.

PHAR 7684. APPE: Required Rotation: Ambulatory Care

6 SCH. Students are involved in the direct care of clinic patients in concert with other healthcare providers. This is a required course.

PHAR 7685. APPE: Required Rotation: Hospital or Health-System Pharmacy

6 SCH. Students participate in all operations of a hospital or health system pharmacy. Students perform clinical duties for hospitalized patients under the supervision of a pharmacist preceptor. This is a required course.

This page last modified February 4, 2013